PepGen Receives U.S. FDA Orphan Drug And Rare Pediatric Disease Designations For PGN-EDO51 For The Treatment Of Duchenne Muscular Dystrophy
PepGen 獲美國 FDA 孤兒藥和罕見兒科疾病認定用於治療杜興氏肌肉萎縮症的 PGN-EDO51
PepGen Receives U.S. FDA Orphan Drug And Rare Pediatric Disease Designations For PGN-EDO51 For The Treatment Of Duchenne Muscular Dystrophy
PepGen 獲美國 FDA 孤兒藥和罕見兒科疾病認定用於治療杜興氏肌肉萎縮症的 PGN-EDO51
使用瀏覽器的分享功能,分享給你的好友吧